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Acne vulgaris is a widespread skin disorder among 
adolescents, and it affects 90% of the individual at some 
point in their life1. Its chronic condition leads to an 
increase in sebum production, resulting in keratinization 
changes, inflammation under hair follicles by 
Propionibacterium acnes. Acne persists for a very long time 
with depressing consequences in adults2,3. Acne is 
commonly treated using benzoyl peroxide, topical 
antibiotics (erythromycin and clindamycin), and topical 
retinoid (tretinoin, isotretinoin, retinaldehyde, and 
retinoyl β-glucuronide)4. 
Isotretinoin is a crystalline yellowish-orange powder 
with a faint odor5. The isotretinoin powder is soluble in 
chloroform and methylene chloride and sparingly 
soluble in water6. Isotretinoin incites apoptosis (cell 
death) in different parts of the body cells. Apoptosis may 
induce hippocampus cells, hypothalamic cells, 
meibomian gland, and vital in acne therapy in sebaceous 
gland cells3,7,8. Isotretinoin has modest interaction for 
retinoid X receptors (RXR) and retinoic acid receptors 
(RAR) but might transform intracellularly to metabolites 
that mimic an agonist RXR nuclear receptors and RAR9. 
Isotretinoin is the exclusive acne drug available which 
influences all vital pathogenic action in acne; it 
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 Abstract 
This study aims to develop a liposomal drug delivery system of 
isotretinoin, an acne drug-using spray drying, as a cost-effective and 
time-effective technique. The liposomal formulation was prepared by 
using spray drying; three different strategies were adopted: 
suspension spray drying (SSD), thin-film hydration and spray drying 
(TFHSD), and emulsion spray drying (ESD). Isotretinoin was 99% 
bound with lipid, so lipids hydrogenated soy phosphatidylcholine 
(HSPC), distearoyl phosphatidylglycerol (DSPG), and cholesterol 
were selected for the formulation development. The HSPC, DSPG, 
cholesterol, and isotretinoin were taken in the ratio 4 : 1 : 0.16 : 3.1 
mmol. In vitro drug release studies, microscopy, drug content, and 
related substance characterizations were done to formulate each 
strategy of spray drying prepared dry liposomes of 
isotretinoin. Results were compared with the USP monograph of 
isotretinoin. It was revealed that isotretinoin's liposomal formulation 
using ESD was having drug release according to the USP limits. Drug 
content was also according to the USP requirement; no free drug 
crystals were found in microscopy, multivesicular vesicles were found 
in shape, a particle size of up 60 µ was found. The ESD technique was 
a successful, time-effective, and cost-effective technique for preparing 
a liposomal drug delivery system for isotretinoin. 
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differentiates from antibiotics treatments and considers 
its therapeutic efficacy in severe, nodulocystic cases. The 
repercussions of isotretinoin on sebum output can be 
short-term, or remission of the disease can be absolute 
and for an extended period10. 
Liposomes are small artificial vesicles of the spherical 
shape created from cholesterol and natural, nontoxic 
phospholipids11,12. Due to their size and hydrophobic and 
hydrophilic character (besides biocompatibility), 
liposomes are promising systems for drug delivery. 
Liposomes are extensively used as carriers for numerous 
molecules in the cosmetic and pharmaceutical 
industries13,14. 
A liposomal drug delivery system was developed for 
isotretinoin using the spray drying technique15. Spray-
drying using a two-fluid nozzle was tested to dry 
liposome preparations, i.e., liposomes composed of 
hydrogenated soy phosphatidylcholine (HSPC), 
distearoyl phosphatidylglycerol (DSPG), cholesterol, and 
isotretinoin. Isotretinoin other products are available in 
the market, such as isotretinoin suspension capsules 
which are expensive16. Isotretinoin shows stability 
problems to overcome these problems and to prepare a 
cost-effective product to dry liposome of isotretinoin was 
prepared using spray drying technique17. Based on this 
background, this study aims to develop liposomal 
preparation of isotretinoin for acne by using the spray 
drying technique. 
 
MATERIALS AND METHODS 
Materials 
Isotretinoin was obtained from Sun Pharmaceuticals, 
Gurgaon, Haryana, India. All solvents (distilled water, 
methanol, and chloroform) were purchased from CDH 
(Central Drug House Pvt. Ltd, New Delhi, India). Other 
ingredients include borate buffer, HSPC, DSPG, 
cholesterol, butylated hydroxyanisole (BHA), butylated 
hydroxytoluene (BHT), mannitol, propyl gallate, and 
phosphate buffer. The instruments used include the UV 
spectrophotometer (Shimadzu), mini spray dryer B-290 
(Buchi), Eclipse E600POL microscope (Nikon), 
differential scanning calorimeter (DSC, Shimadzu), 
rotary evaporator, high-pressure homogenizer (HPH), 
and dissolution test apparatus type II (paddle). 
Methods 
Physical characterization of isotretinoin 
Solubility – The saturation solubility studies of class II 
model drug-like isotretinoin were conducted as per 
Biopharmaceutics Classification System (BCS) 
guidelines18. An excess amount of isotretinoin was placed 
in pH borate buffer at room temperature and stirred until 
saturation point. After 24 hours, the sample was filtered, 
suitably diluted, and absorbance was taken at 346 nm 
against pH 8 borate buffer as blank on UV 
spectrophotometer. The excipient and drug solubility 
were observed in the solvent, i.e., water, methanol, and 
chloroform, to optimize the ratio of solvent combination, 
i.e., chloroform : methanol (1 : 1) and chloroform : 
methanol (2 : 1). 
Quantitative estimation of isotretinoin – The UV 
spectrophotometric method was used to estimate the 
drug because the method was simple, economical, and 
gives reproducible results within acceptable limits. The 
double beam UV spectrophotometer was used for 
analysis19. Isotretinoin was dissolved in borate buffer pH 
8.0 containing 0.5% cetrimide. The solution was scanned 
for maximum absorbance in a UV double beam 
spectrophotometer in the range from 200 to 400 nm, 
using the respective solution as a blank. 
Selection of lipids – Optimization batches were prepared to 
optimize the number of lipids. Initially, the quantities 
were taken in 2 : 1 mmol of HSPC and cholesterol, 
respectively. The Amount of DSPG was kept constant at 
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0.16 mmol. Tests were carried out on three batches with 
variations in the number of HSPCs, as shown in Table I. 
Table I. Optimization of lipids use for formulation 









1 2 1 0.16 
2 3 1 0.16 
3 4 1 0.16 
 
Excipients were dissolved in the solvent and then spray-
dried by mini spray dryer B-290 with an inlet 
temperature of 70°C, the outlet temperature of 42°C, 
aspirator rate was kept at 70%, nitrogen pressure was at 
2 kg/cm2, and pump rate kept at 5%. The spray-dried 
powder was collected and dispersed in an appropriate 
amount of water and then observed under a microscope 
using a 50X lens. 
Drug loading – Pre-optimization studies of isotretinoin 
liposomal formulation were tried to formulate along with 
the lipids, HSPC, DSPG, and cholesterol to optimize the 
drug loading for the isotretinoin liposome formulation. A 
review of the literature revealed that these were the lipids 
that can be used in formulation development. Thus, for 
selection of the range, various pre-optimization trials 
were done with the exact quantities of lipids but with the 
increasing quantity of isotretinoin20, as shown in Table II. 


















1 4 1 0.16 0.25 
2 4 1 0.16 0.5 
3 4 1 0.16 1 
4 4 1 0.16 1.4 
5 4 1 0.16 2.2 
6 4 1 0.16 3.1 
 
All ingredients were dissolved in chloroform : methanol 
(2 : 1) solvent and spray-dried at the same parameters 
used earlier in this study. Batches were manufactured 
with isotretinoin quantities of 0.25 mmol to 3.1 mmol to 
check the solubility of the drug in a given excipient. 
Resulted in dried drug lipid dry powder was dispersed 
in phosphate buffer pH 6.8 and observed for 
multivesicular vesicles and free drug crystals using a 
microscope with a 50X lens. 
Differential scanning calorimetry – Differential scanning 
calorimetry experiments were performed with DSC. 
Sample of isotretinoin and spray dried liposomal 
formulation containing isotretinoin and lipids (HSPC, 
DSPG, and cholesterol) were submitted to DSC analysis. 
The analysis was performed on 5 mg samples sealed in 
standard aluminum pans. Thermograms were obtained 
at a scanning rate of 10°C/minutes. Each sample was 
scanned between 0°C to 200°C. The temperature of 
maximal heat capacity was defined as the phase 
transition temperature21. 
Preparation of liposomal formulation of isotretinoin 
Isotretinoin liposomes were prepared by using a spray 
drying technique. The spray drying technique was 
employed through three different strategies, i.e., 
suspension spray drying (SSD), thin-film hydration and 
spray drying (TFHSD), and emulsion spray drying 
(ESD). 
Suspension spray drying 
The solution of suspension spray drying was prepared 
by dissolving HSPC, cholesterol, DSPG, and isotretinoin 
in the ratio of 4 : 1 : 0.16 : 3.1 mol, respectively. These 
ingredients were dissolved in chloroform : methanol (2 : 
1) solvent. The DSPG was dissolved in the solvent in the 
presence of heat 60°C to prevent aggregates formation. 
Ingredients other than DSPG are mixed with the swirling 
of the solution22. The suspension was spray-dried with a 
mini spray dryer B-290 combined with inert loop B-295 at 
the following parameter: inlet temperature 60-80°C; 
outlet temperature 38-45°C; aspirator rate at 50-70%; 
pump rate at 5-10%; and nitrogen pressure 2 kg/cm2. The 
Borneo Journal of Pharmacy, Vol 4 Issue 2, May 2021, Page 117 – 127  e-ISSN: 2621-4814 
120 
dried powder so retained from the spray drier was 
characterized further. The batch was named SSD 1. 
Thin-film hydration and spray drying 
The TFHSD technique's objective was to overcome the 
hygroscopicity problem that was coming in the previous 
SSD23. The TFHSD was conducted in several steps. 
Preparation of solution – The solution for dispersion spray 
drying was prepared with the same composition and 
according to the optimized amount. This was done in the 
solution spray drying method. Antioxidants BHA and 
BHT was added within allowed daily intake limits. 
Thin-film formation using rotary evaporator – Thin-film of 
the solution containing formulation was the suitable 
organic solution formed using the rotary evaporator at 
the following parameters: bath temperature 450°C; RPM 
30; vacuum 250-500 mm of Hg for 1 hour24. 
Hydration of thin-film with Buffer containing 5% mannitol – 
The hydration of the thin-film was prepared using 
phosphate buffers pH 6.8 and 5% mannitol in it. The 
hydration was carried out for 1-2 hours. The appropriate 
amount of the buffer was put in the rotary evaporator 
vessel over the thin-film, so the formed process started 
again with temperature 50-55°C, and vacuum was 
applied. If a problem occurs in hydration, sonication was 
performed to recollect the total amount of material24. The 
above suspension was passed through the HPH to 
reduce the size of the particles in the suspension. 
Spray drying – The prepared suspension so obtained from 
HPH was then spray-dried using mini spray dryer B-290 
with the following parameters: aspirator rate 70%; inlet 
temperature 80°C; outlet temperature 52°C; and pump 
rate 5%. The spray drying was performed using air as 
well as nitrogen. The dried powder was collected and 
was analyzed. This technique was employed to 
overcome the hygroscopicity25. Only related substance 
characterization was done of TFHSD. The batch was 
named TFHSD 1. 
Emulsion spray drying 
Emulsion spray drying was the technique in which 
emulsion was prepared by emulsifying organic solvent 
containing drug and lipids with water containing 
mannitol using high-speed homogenization25. The ESD 
was performed in several steps. 
Preparation of the organic and aqueous phases – The organic 
phase and aqueous phase ratios were kept at 70% and 
30%, respectively. The organic solution was prepared 
with the optimized quantities of the Excipient and the 
drug. The composition used was HSPC : cholesterol : 
DSPG : isotretinoin (4 : 1 : 0.16 : 3.1 mol, respectively), 
BHA, BHT, and propyl gallate (within allowed daily 
intake limits). These all were mixed in the solvent of 
chloroform and methanol (2 : 1), making 5% w/w 
solution, and then processed further. Mannitol (2.5/5 
times of drug quantity) was dissolved in a suitable 
amount of distilled water. 
High-speed homogenization – The aqueous solution was 
added drop-wise to an organic solution under high-
speed homogenization for speed up to 18000 RPM, 
resulting in an emulsion26. The homogenization was 
done for 5 minutes with breaks for 10 seconds after 2, 3, 
and 4 minutes in between to avoid overheating due to 
heat generation. 
Spray drying – The prepared emulsion was then spray 
dried using the following parameters: inlet temperature 
70°C; outlet temperature 42°C; aspirator rate 70%; pump 
rate 5%; nitrogen pressure 2 kg/cm2; and humidity of 
room 55-60%. The spray-dried powder was collected and 
filled in the hard gelatin capsules, and analyzed further. 
The batch was named ESD 1. 
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Physical characterization of isotretinoin liposomal formulation 
Drug content – As much as 10 mg of spray-dried powder 
was dissolved in 100 mL of solvent, i.e., chloroform : 
methanol (2 : 1) in a 100 mL volumetric flask. As much as 
2 mL was taken from this solution and diluted up to 10 
mL with the solvent in a 10 mL volumetric flask. The 
absorbance of the resulting solution was measured at the 
maximum at 346 nm using a UV spectrophotometer27. 
The linearity equation obtained from the calibration 
curve was used to estimate isotretinoin in the liposomal 
formulations. Results were compared with the USP 
monograph limits. 
In vitro release studies – The release rate of 40 mg capsule 
isotretinoin liposomal formulation was determined 
using type II dissolution test apparatus. The dissolution 
test was carried out using 900 mL of borate buffers pH 8 
with pancreatin at 37±0.5°C and 100 RPM using a 40-
mesh basket. Sample no. 108 (10 mL) was withdrawn 
from the dissolution apparatus and replaced with a fresh 
medium. Sample no. 109 was filtered through a 0.45 μm 
membrane and diluted to a suitable solvent. The 
absorbance of samples was measured at 346 nm using a 
UV spectrophotometer, and cumulative drug release 
was calculated28. Sample no. 110 drug release data were 
analyzed using PCP Disso software version 2.08. The 
dissolution profile of all the batches was fitted to zero-
order, first-order, Higuchi, Hixson-Crowell, as well as 
Korsmeyer and Peppas to ascertain the kinetic modeling 
of drug release, and the model with the highest 
correlation coefficient was considered to be the best 
mode. Results were compared with the USP monograph 
limits. 
Microscopy – Liposomal dispersion was prepared by 
dispersing spray-dried formulation in phosphate buffer 
pH 6.8 and was observed under 50X lens under 
Polarizing microscope. The microscopy revealed the 
particle size, shape of vesicles (regular or irregular), and 
free drug crystals29. The 50X resolution lens was used for 
the particle size analysis. In a microscope, 1 unit of the 
scale present on the lens was taken as 2µ. The required 
amount of blend was reconstituted with the necessary 
amount of water, and then the slide was prepared and 
observed under a microscope. 
Related substances (detection of impurity) – This 
characterization was done to check impurities in the 
prepared liposomal formulation of isotretinoin—5,6 
epoxy-13-cis retinoic acid, tretinoin, and others 
unknown. Some impurities were observed with the 
related substance test of the liposomal formulation30. The 
results were compared with the USP monograph limits. 
 
RESULTS AND DISCUSSION 
Physical characterization of isotretinoin 
Solubility studies – The isotretinoin was found to be 
yellowish-orange, crystalline powder with a faint odor 
that resembles vitamin A. The drug was insoluble in 
water, whereas it was soluble in the organic solvent, 
thereby suggesting it was lipophilic. Chloroform : 
methanol (2 : 1 respectively) was taken for the 
formulation as solvents. Isotretinoin exhibits solubility 
across the borate buffer pH 8. Therefore, it could be 
classified as a “less soluble” material. A review of the 
literature revealed that the drug exhibits high 
permeability. According to BCS classification, if the 
highest dose of the drug was insoluble in aqueous media 
and exhibited high permeability, it was called a BCS class 
II drug18. Therefore, the isotretinoin falls under BCS class 
II. 
Selection of lipids – Excipient for isotretinoin liposomal 
formulation was selected based on maximum solubility, 
in which isotretinoin was found to be a lipophilic drug. 
Batches were prepared and observed under the 
microscope 50X lens for free drug crystals, and the shape 
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and size of vesicles formed to determine the excipient 
ratios used. Batch no. 1 had shown the presence of free 
drug crystals while vesicles were irregular in shape. 
Batch no. 2 had also shown the presence of free drug 
crystals, and vesicles were also irregular in shape and 
size. Batch no. 3 had not shown any free drug crystals, but 
multivesicular structures were regular in round shapes. 
As observed, batch 3 excipient ratios were selected for the 
preparation of the liposomal formulation31. Clear 
vesicular structures with no free drug crystals found with 
HSPC : cholesterol 4 : 1. Therefore, the 4 : 1 ratio was 
found to be sufficient. 
Drug loading – Isotretinoin quantity of 3.1 mol resulted in 
powder blend, which contains 40 mg drug in 200 mg 
blend. Hygroscopicity was observed, and for the 
collection of spray-dried powder, RH was maintained 
below 25%. The collected powder was filled in 00 sizes 
hard gelatin capsule with a suitable amount. Further 
increase in drug quantity leads to free drug crystals. The 
drug loading of various batches in different quantities 
was presented in Table III. 





1 0.25 No free drug crystals were found. 
Multivesicular structures were 
observed but the powder was 
sticky because of relative humidity 
i.e. 60% 
2 0.5 No free drug crystals, dry powder. 
Relative humidity maintained 
below 25%. Large multivesicular 






Differential scanning calorimetry – Differential scanning 
calorimetry study was carried out for isotretinoin and 
drug-loaded dry liposome’s containing lipids (HSPC, 
DSPG, and cholesterol). The DSC thermograms of 
isotretinoin and drug-loaded dry liposomes were 
illustrated in Figures 1 and 2, respectively. The DSC 
thermogram of isotretinoin showed endothermic at 
181.73°C. It proves that the isotretinoin was pure32. 
The DSC thermogram of drug-loaded dry liposomes 
with lipids showed endothermic at 76.58°C. The DSC 
thermogram of isotretinoin-loaded liposomes composed 
of HSPC, DSPG, cholesterol, and isotretinoin in the ratio 
of 4 : 1 : 0.16 : 3.1, respectively, showed the disappearance 
of melting endothermic of isotretinoin and major 
endothermic was observed at 76.58°C. The absence of the 
melting endothermic of isotretinoin suggested significant 
interaction of isotretinoin with lipids leading to enhanced 
entrapment of the drug33. The isotretinoin was dissolved 
in lipids. The incorporated isotretinoin was associated 
with lipids and interacted to a large extends with them. 
The DSC results of liposome’s suggested enhanced 
entrapment efficiency of isotretinoin in a lipid bilayer. 
Microscopy – Microscopy of batches was done to observe 
particle size, shape, and free drug crystals. The particle 
size multivesicular vesicles of sizes 2 to 60µ were 
observed. Figures 3a and 3b of SSD 1 microscopy 
showed that multivesicular vesicles of drug solubilized 
lipids were found. Free drug crystals were not found. The 
drug was solubilized entirely in lipids. In Figure 3c of 
TFHSD 1, microscopy-free drug crystals were found, and 
the size and shape of the vesicles were also irregular. 
Thus, the strategy was dropped, but beneficial points 
were taken into considerations from this strategy, such as 
this strategy was successfully able to remove 
hygroscopicity. In Figure 3d of ESD 1, microscopy large 
lipid vesicles in the aqueous medium were found. No 
free drug crystals were found. 
In SSD 1, no free drug crystals were found, and the 
vesicles were also in regular shape and size, which states 
that the drug was utterly solubilized in lipids34. In ESD 1, 
large lipid vesicles were found, and no free drug crystals 
were found. Thus, both these strategies pass the 
microscopy test. In TFHSD 1, free drug crystals were 
found, and the vesicles were irregular in shape; this 
strategy fails the microscopy test. 
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Figure 1. Differential scanning calorimetry thermogram of isotretinoin 
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a    b 
 
c    d 
Figure 3. The SEM images of SSD 1 (a and b), TFHSD 1 (c), and 
ESD 1 (d) taken at 20,000x magnification 
 
Physical characterization of isotretinoin liposomal formulation 
Drug content – The formulation should contain not less 
than 90.0% and not more than 110.0% of the labeled 
amount of drug according to the USP monograph [120]. 
The triplicate batches were prepared for every strategy, 
and the assay was also done in triplicate average best 
assay results35. Batch SSD 1 had shown drug content 
96.6%, while batch ESD 1 had shown 91.1% of drug 
content. The assayed drug content in formulations ranges 
from 90.0 % to 110.0 %, which were under the USP limit. 
In vitro drug release – The in vitro drug release studies were 
performed in borate buffer with pancreatin to determine 
the release of the drug. The dissolution profiles of all the 
formulations were determined and shown in Figure 4. 
The results were analyzed by plotting cumulative drug 
release/time. The dissolution was done in low intensity 
of light as the drug was light-sensitive. The dissolution 
was done in triplicates of each strategy. 
The average best results were shown in Figure 4—the 
dissolution profile of SSD 1 and ESD 1. According to the 
USP monograph, 70% of the drug should be released in 
90 minutes. Dissolution of SSD 1 batch slow-release, 
which did not fulfill the USP requirement as there was 
61% release in 90 minutes. Dissolution of ESD 1 batch 
95% release in 90 minutes fulfills USP requirement and 
shows immediate release action36. 
 
Figure 4. In vitro drug release profile 
 
Related substances – The related substance analysis was 
done to detect impurity in the formulation, which was 
compared with the USP limits37. The analysis was done 
in triplicates of each batch, and the best results were given 
in Table IV. The analysis revealed that the impurities of 
batch SSD 1 and ESD 1 were according to the USP limits. 
The impurities of batch THFSD 1 (using nitrogen; 1N and 
using air; 1A) were not found out of the limits of USP. 












(peak 1 and 2) 
0.5 0.22± 0.1 0.11± 0.3 1.2± 0.5 0.05± 0.1 
Tretinoin 0.2 0.07± 0.2 0.38± 0.5 0.36± 0.3 0.14± 0.1 
Highest unknown 0.1 0.07± 0.1 0.07± 0.2 0.1± 0.1 0.05± 0.1 
Total unknown 0.5 0.24± 0.4 - - 0.14± 0.3 
Total related 
substances 
1.5 0.53± 0.2 - - 0.33± 0.4 
 
CONCLUSION 
Dry liposomes of isotretinoin were successfully prepared 
using three different strategies of spray drying, i.e., SSD, 
TFHSD, and ESD. The formulation of each respective 
strategy was analyzed. Related substance (impurity 
study) revealed that the impurities of SSD and ESD were 
under the USP limits, whereas the impurities of TFHSD 
were out of USP limits, so the formulation of two 
strategies SSD and ESD, were further analyzed. 
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through ESD was found successful, time-effective, and 
cost-effective in comparison with the other two strategies. 
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